Pharmaceutical product permissions

A searchable record of what Walter is equipped to evaluate.

Explore compositions across oral solids, oral liquids, sterile injectables, topical formats and selected specialist presentations. Use the catalogue to begin a technical and commercial discussion—not as a substitute for written facility-specific confirmation.

5,500Distinct records
21Dosage forms
407Sterile injectable records
17Therapeutic indexes

Built for portfolio teams

Move from a molecule search to a focused feasibility conversation.

The catalogue brings together composition, strength, pharmacological class, dosage form, manufacturing stream, BCS class and documented regulatory references. It also incorporates products listed in Walter’s March 2025 Injectables Manufacturing Profile. Therapeutic and pharmacological classes are practical navigation labels; final indication, regulatory position and site suitability are confirmed product by product.

Search the catalogue

Selected catalogue briefs

Explore a composition for your manufacturing brief.

Browse selected compositions by dosage form, then share the required strength, pack, quantities and target market for a product-specific feasibility review.

Search the full catalogue
Browse 26 selected composition briefs

Therapeutic index

Begin with the treatment area.

Each composition is assigned to one practical primary area for navigation. Combination products may span more than one clinical use and remain subject to product-specific review.

Searchable permissions catalogue

Find a composition, dosage form or capability route.

5,500distinct permission records

Loading full catalogue search…
Therapeutic area
Dosage-form family
Specific dosage form
Pharmacological class
Manufacturing stream
BCS classification
Confirmed CDSCO category
Drugs Rules status

24 records shown

Other & specialty productsPRM 0067
Dosage formTablets
Oral

Activated Charcoal 75 mg, Fungal Diastase (1:800) 100 mg, Papain 60 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Specialty therapeutic agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Local
CDSCO categoryFDC
Documented match

FDC Category C continued-manufacture listing

CDSCO filing reference · page 494
Other & specialty productsPRM 1977
Dosage formDry-powder injectables
Parenteral

Amphotericin B 50 mg

Route
Parenteral
Formulation type
Sterile powder for injection
Pharmacological class
Antifungal
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Parenteral
CDSCO categorySND
Documented match

New or additional dosage form

CDSCO filing reference · page 779
Other & specialty productsPRM 1493
Dosage formSyrup
Oral

Antioxidant With B-Complex

Route
Oral
Formulation type
Oral liquid syrup
Pharmacological class
Specialty therapeutic agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Other & specialty productsPRM 0226
Dosage formTablets
Oral

Azathioprine 50 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Specialty therapeutic agent
Manufacturing stream
Non-beta-lactam
BCS class
Class IV
Drugs Rules status
Schedule HList or category match
CDSCO categoryNew Drug
Documented match

Listed in CDSCO New Drug approval records

CDSCO filing reference · page 381
Other & specialty productsPRM 1674
Dosage formOral suspension
Oral

Bacillus Clausii 2 Billion Spores / 5 ml

Route
Oral
Formulation type
Oral liquid suspension
Pharmacological class
Specialty therapeutic agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Other & specialty productsPRM 2104
Dosage formDry-powder injectables
Parenteral

Benzathine Penicillin 3600000 Units

Route
Parenteral
Formulation type
Sterile powder for injection
Pharmacological class
Penicillin antibiotic
Manufacturing stream
Beta-lactam
BCS class
N/A — Parenteral
Drugs Rules status
Schedule HList or category match
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Other & specialty productsPRM 1987
Dosage formDry-powder injectables
Parenteral

Bleomycin

Route
Parenteral
Formulation type
Sterile powder for injection
Pharmacological class
Specialty therapeutic agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Parenteral
Drugs Rules status
Schedules G & HListed in both schedules
CDSCO categoryNew Drug
Documented match

Listed in CDSCO New Drug approval records

CDSCO filing reference · page 634
Other & specialty productsPRM 1507
Dosage formSyrup
Oral

Buclizine 12 mg / 5 ml

Route
Oral
Formulation type
Oral liquid syrup
Pharmacological class
Specialty therapeutic agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Oral Liquid
Drugs Rules status
Schedule GListed substance
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Other & specialty productsPRM 1520
Dosage formSyrup
Oral

Carica Papaya Leaf 375 mg, Tinospora Cordifolia 125 mg

Route
Oral
Formulation type
Oral liquid syrup
Pharmacological class
Specialty therapeutic agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Other & specialty productsPRM 2219
Dosage formHard-gelatin capsules
Oral

Caroverine 20 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Specialty therapeutic agent
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Other & specialty productsPRM 1813
Dosage formLiquid injectables
Parenteral

Chlorampheniramine Maleate 10 mg

Route
Parenteral
Formulation type
Sterile liquid injectable
Pharmacological class
Specialty therapeutic agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Parenteral
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Other & specialty productsPRM 0408
Dosage formTablets
Oral

Chlordiazepoxide 10 mg, Trifluoperazine 1 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Anxiolytic
Manufacturing stream
Non-beta-lactam
BCS class
Class II
Drugs Rules status
Schedule H1Listed substance
CDSCO categoryFDC
Documented match

Listed in CDSCO FDC approval records

CDSCO filing reference · page 697
Other & specialty productsPRM 0409
Dosage formTablets
Oral

Chlordiazepoxide 5 mg, Clidinium Bromide 2.5 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Anxiolytic
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Drugs Rules status
Schedule H1Listed substance
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Other & specialty productsPRM 0448
Dosage formTablets
Oral

Chymotrypsin 1 Lac IU, Trypsin 1 Lac IU

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Specialty therapeutic agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Other
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Other & specialty productsPRM 0445
Dosage formTablets
Oral

Chymotrypsin 2 Lac IU, Trypsin 2 Lac IU

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Specialty therapeutic agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Other
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Other & specialty productsPRM 0458
Dosage formTablets
Oral

Cinitapride 1 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Specialty therapeutic agent
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Other & specialty productsPRM 0466
Dosage formTablets
Oral

Cintapride 1 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Specialty therapeutic agent
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Other & specialty productsPRM 1999
Dosage formDry-powder injectables
Parenteral

Cistracurium Besylate

Route
Parenteral
Formulation type
Sterile powder for injection
Pharmacological class
Specialty therapeutic agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Parenteral
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Other & specialty productsPRM 2436
Dosage formDry-powder injectables
Parenteral

Clavulanic Acid 3100 mg, Ticarcillin

Route
Parenteral
Formulation type
Sterile powder for injection
Pharmacological class
Specialty therapeutic agent
Manufacturing stream
Beta-lactam
BCS class
N/A — Parenteral
Drugs Rules status
Schedule HList or category match
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Other & specialty productsPRM 0491
Dosage formTablets
Oral

Clonidine 100 mcg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Antihypertensive
Manufacturing stream
Non-beta-lactam
BCS class
Class I
Drugs Rules status
Schedule HList or category match
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Other & specialty productsPRM 1821
Dosage formLiquid injectables
Parenteral

Closantel 100 mg

Route
Parenteral
Formulation type
Sterile liquid injectable
Pharmacological class
Specialty therapeutic agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Parenteral
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Other & specialty productsPRM 2437
Dosage formDry-powder injectables
Parenteral

Co-Amoxiclav 1200 mg

Route
Parenteral
Formulation type
Sterile powder for injection
Pharmacological class
Specialty therapeutic agent
Manufacturing stream
Beta-lactam
BCS class
N/A — Parenteral
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Other & specialty productsPRM 0500
Dosage formTablets
Oral

Co-Trimoxazole

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Specialty therapeutic agent
Manufacturing stream
Non-beta-lactam
BCS class
Class II
Drugs Rules status
Schedule HList or category match
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Other & specialty productsPRM 1822
Dosage formLiquid injectables
Parenteral

Colistimethate 1 Million IU

Route
Parenteral
Formulation type
Sterile liquid injectable
Pharmacological class
Specialty therapeutic agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Parenteral
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Explore the product catalogue

Browse product pages by therapeutic area.

Browse compositions, strengths and dosage forms for third-party and contract manufacturing enquiries. Each product page includes its catalogue specification, manufacturing and packaging considerations, and a product-specific enquiry link. Confirm the applicable unit, documents and commercial terms with Walter.

How to read this catalogue

Permission is a starting point—not a supply commitment.

01

Therapeutic index

Primary areas provide buyer-friendly navigation. Combination products may reasonably sit across several clinical categories.

02

Facility confirmation

Current licence scope, site allocation, equipment fit and applicable segregation requirements are checked before commitment.

03

Product feasibility

Formula, strength, presentation, pack, target market, testing requirements and commercial scale are assessed together.

04

Responsible use

This B2B catalogue is not prescribing information, patient guidance or a representation that every composition is currently available for sale.

Start the conversation

Found a composition worth discussing?

Use the enquiry link on any record to carry its composition and dosage form into your manufacturing brief.

Request a quote
Quick chat on WhatsAppLet’s discuss your product